Market
Bridge to Life raises $110m to advance liver perfusion system’s rollout
Bridge to Life secured $110 million in funding to support US commercialization of its VitaSmart liver perfusion system, expand its product portfolio, and scale global operations. The capital will accelerate market entry and broader international deployment of the organ perfusion technology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network